ATE214269T1 - Oral anzuwendende flüssige arzneilösung - Google Patents

Oral anzuwendende flüssige arzneilösung

Info

Publication number: ATE214269T1
Authority: AT; Austria
Prior art keywords: medicinal solution; oral application; liquid medicinal; weight; volume
Prior art date: 1997-06-27

Application number

AT98202077T

Other languages

English (en)

Inventor

Roger Edward Tully

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-27

Filing date

1998-06-23

Publication date

2002-03-15

1998-06-23 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

2002-03-15 Application granted granted Critical

2002-03-15 Publication of ATE214269T1 publication Critical patent/ATE214269T1/de

Links

239000007788 liquid Substances 0.000 title 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
239000000654 additive Substances 0.000 abstract 2
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
230000000996 additive effect Effects 0.000 abstract 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
239000008297 liquid dosage form Substances 0.000 abstract 1
229940100688 oral solution Drugs 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
239000000600 sorbitol Substances 0.000 abstract 1
229960003454 tamoxifen citrate Drugs 0.000 abstract 1
FQZYTYWMLGAPFJ-OQKDUQJOSA-N tamoxifen citrate Chemical compound [H+].[H+].[H+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 FQZYTYWMLGAPFJ-OQKDUQJOSA-N 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT98202077T 1997-06-27 1998-06-23 Oral anzuwendende flüssige arzneilösung ATE214269T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP97201964		1997-06-27

Publications (1)

Publication Number	Publication Date
ATE214269T1 true ATE214269T1 (de)	2002-03-15

Family

ID=8228492

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98202077T ATE214269T1 (de)	1997-06-27	1998-06-23	Oral anzuwendende flüssige arzneilösung

Country Status (8)

Country	Link
US (1)	US6127425A (de)
EP (1)	EP0893121B1 (de)
JP (1)	JPH1171269A (de)
AT (1)	ATE214269T1 (de)
DE (1)	DE69804169T2 (de)
DK (1)	DK0893121T3 (de)
ES (1)	ES2174388T3 (de)
PT (1)	PT893121E (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6136799A (en) *	1998-04-08	2000-10-24	Abbott Laboratories	Cosolvent formulations
FI109332B (fi)	1998-12-17	2002-07-15	Orion Yhtymae Oyj	Toremifeenin liukoisia koostumuksia
FI982733L (fi)	1998-12-17	2000-06-18	Orion Yhtymae Oyj	Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
US6541367B1 (en) *	2000-01-18	2003-04-01	Applied Materials, Inc.	Very low dielectric constant plasma-enhanced CVD films
FR2910317B1 (fr) *	2006-12-21	2009-02-13	Philippe Perovitch	Forme galenique pour l'administration par voie transmuqueuse de paracetamol
KR101025498B1 (ko) *	2008-05-02	2011-03-31	(주)이엘티사이언스	염산브롬헥신 경구용 액제 복합조성물 및 그 제조방법
WO2012142029A2 (en)	2011-04-10	2012-10-18	Florida A&M University	Serms for the treatment of estrogen receptor-mediated disorders
ITUA20162292A1 (it) *	2016-04-05	2017-10-05	Gb Pharma S R L	Uso del tamoxifene per il trattamento della fibrosi cistica in pazienti di entrambi i sessi

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE293263C (de) *
WO1984001506A1 (en) *	1982-10-13	1984-04-26	Univ Birmingham	Pharmaceutical preparations for use in antitumour therapy
GB8604528D0 (en) *	1986-02-24	1986-04-03	Ici Plc	Therapeutic agents
DD293263A5 (de) *	1990-03-23	1991-08-29	Adw,Zi Fuer Molekularbiologie,De	Mittel zur hemmung des tumorwachstums
GB9126209D0 (en) *	1991-12-10	1992-02-12	Orion Yhtymae Oy	Drug formulations for parenteral use
IT1263831B (it) *	1993-01-29	1996-09-04	Paolo Chiesi	Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
DE4335876A1 (de) *	1993-10-17	1995-04-20	Schering Ag	Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen
US5683993A (en) *	1995-06-22	1997-11-04	Ciba Vision Corporation	Compositions and methods for stabilizing polymers
TW389694B (en) *	1995-08-17	2000-05-11	Novartis Ag	Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics

1998
- 1998-06-23 DK DK98202077T patent/DK0893121T3/da active
- 1998-06-23 DE DE69804169T patent/DE69804169T2/de not_active Expired - Lifetime
- 1998-06-23 PT PT98202077T patent/PT893121E/pt unknown
- 1998-06-23 EP EP98202077A patent/EP0893121B1/de not_active Expired - Lifetime
- 1998-06-23 AT AT98202077T patent/ATE214269T1/de active
- 1998-06-23 ES ES98202077T patent/ES2174388T3/es not_active Expired - Lifetime
- 1998-06-24 JP JP10176890A patent/JPH1171269A/ja not_active Withdrawn
- 1998-06-26 US US09/106,172 patent/US6127425A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0893121B1 (de)	2002-03-13
DE69804169T2 (de)	2002-08-29
JPH1171269A (ja)	1999-03-16
PT893121E (pt)	2002-06-28
DK0893121T3 (da)	2002-06-17
ES2174388T3 (es)	2002-11-01
US6127425A (en)	2000-10-03
DE69804169D1 (de)	2002-04-18
EP0893121A1 (de)	1999-01-27

Similar Documents

Publication	Publication Date	Title
KR870700620A (ko)	1987-12-30	신규 약리학적 화합물
NO870241D0 (no)	1987-01-20	Hypoglykemiske tiazolidindioner.
EA200000920A1 (ru)	2001-02-26	Производные бициклических гидроксамовых кислот
EA200200431A1 (ru)	2002-10-31	Фармацевтические композиции, обеспечивающие повышенные концентрации лекарства
FR2692264B1 (fr)	1994-08-05	Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
ATE64306T1 (de)	1991-06-15	Mittel zur erhoehung der transdermalen permeation.
LV10954A (lv)	1995-12-20	Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
NO940523L (no)	1994-02-15	Nye pyrazin-derivater
KR890016966A (ko)	1989-12-14	신규 항바이러스제
FR2712807B1 (fr)	1996-02-23	Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
ATE214269T1 (de)	2002-03-15	Oral anzuwendende flüssige arzneilösung
JPS54160753A (en)	1979-12-19	Nail enamel
ATE80313T1 (de)	1992-09-15	Mittel zur erhoehung des transdermalen penetrationsflusses.
KR880007060A (ko)	1988-08-26	제약 조성물
DE69531736D1 (de)	2003-10-16	Oxytetracyclin enthaltendes arzneimittel mit verzögerter wirksoffabgabe
FI953566A0 (fi)	1995-07-26	Tahdospironia tai sen analogeja sisältäviä koostumuksia
FI803202L (fi)	1981-04-13	Fosfonohydroxiaettiksyra foerfarande foer dess framstaellning och dess anvaendning saosom laekemedel
JPS5781409A (en)	1982-05-21	External plaster
IT1187743B (it)	1987-12-23	Composizioni farmaceutiche a base di destrorfano per applicazione instranasale
KR900017581A (ko)	1990-12-19	α-아미노보론산 유도체를 함유하는 펩티드-약제 조성물
KR920019349A (ko)	1992-11-19	불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
KR880012518A (ko)	1988-11-28	나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물
FI820172L (fi)	1982-07-23	Basiskt substituerade antranilsyror deras framstaellningsfoerfarande och anvaendning
JPS5762221A (en)	1982-04-15	Embrocation for external use
SE8104675L (sv)	1982-02-06	Farmacevtisk komposition med antiflogistisk, antipyretisk och analgetisk verkan

Legal Events

Date	Code	Title
2002-08-15	UEP	Publication of translation of european patent specification
2005-05-15	EEIH	Change in the person of patent owner
2007-01-15	EEIH	Change in the person of patent owner